Carbidopa

Product NDC: 68682-200
11-digit product format: 686820200
Labeler code: 68682
Product ID: 68682-200_ccf10efe-4fda-40a4-8f20-1ccefb151a15
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Carbidopa Tablets
Dosage form: TABLET
Route: ORAL
Labeler: Oceanside Pharmaceuticals
Application: NDA017830
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2014-04-04
Substance: CARBIDOPA
Active strength: 25 mg/1
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N017830-001	LODOSYN	CARBIDOPA	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N017830-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N017830-001	LODOSYN	25MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N017830-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N017830-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N017830-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N017830-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N017830-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N017830-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N017830-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N017830-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N017830-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N017830-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N017830-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N017830-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N017830-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N017830-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N017830-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N017830-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N017830-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N017830-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N017830-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N017830-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N017830-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N017830-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N017830-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N017830-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N017830-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N017830-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N017830-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N017830-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N017830-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N017830-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N017830-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N017830-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N017830-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N017830-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N017830-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N017830-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N017830-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N017830-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N017830-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N017830-001	AB	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Carbidopa
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CARBIDOPA	25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
MNX7R8C5VO	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
260260	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
d5204e5e-10ef-4758-8fc6-cb710048c687	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
5ce6fab2-d006-4589-8ba0-02cee499cc60	Product name	2	20260128
ebf3b793-6fcd-797b-9d2e-c3faf6d29442	Product name	5	20251106
162160fe-5ea6-4f9d-aa38-c4b780c57046	Product name	1	20250515
0e5ae331-9620-4d1f-8061-7c437c7f1c42	Product name	1	20250312
028fdaca-77da-0dfe-e445-7dfc440fc97e	Product name	4	20250224
7d015b89-35e8-b484-e5db-c0c44814f63c	Product name	7	20241218
de702a02-e9c0-4daf-9101-e44f2c0d4e66	Product name	1	20220609
7d015b89-35e8-b484-e5db-c0c44814f63c	Product name	4	20171212
1fa100ae-9ab3-4df0-afe7-33ab01fd4a41	Product name	1	20150313
88839c8d-b65b-4a50-997b-4c74539855ff	Product name	1	20150313

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68682-200-25	Carbidopa	100 in 1 BOTTLE	TABLET	100		8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68682-200-25	EA - Each	68682-200	ee1af7da-3d0c-4d9f-88b7-c1a6e0eff130	1	2014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
carbidopa	ACTIVE INGREDIENT	MNX7R8C5VO	CARBIDOPA (CARBIDOPA TABLETS) TABLET [OCEANSIDE PHARMACEUTICALS]	5
carbidopa anhydrous	ACTIVE MOIETY	KR87B45RGH	CARBIDOPA (CARBIDOPA TABLETS) TABLET [OCEANSIDE PHARMACEUTICALS]	5
FD&C Yellow No. 6	INACTIVE INGREDIENT	H77VEI93A8	CARBIDOPA (CARBIDOPA TABLETS) TABLET [OCEANSIDE PHARMACEUTICALS]	5
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	CARBIDOPA (CARBIDOPA TABLETS) TABLET [OCEANSIDE PHARMACEUTICALS]	5
powdered cellulose	INACTIVE INGREDIENT	SMD1X3XO9M	CARBIDOPA (CARBIDOPA TABLETS) TABLET [OCEANSIDE PHARMACEUTICALS]	5
starch, corn	INACTIVE INGREDIENT	O8232NY3SJ	CARBIDOPA (CARBIDOPA TABLETS) TABLET [OCEANSIDE PHARMACEUTICALS]	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68682-200	CARBIDOPA (CARBIDOPA TABLETS) TABLET [OCEANSIDE PHARMACEUTICALS]	8	Current NDC, Legacy NDC, 1 package rows	20200825_d5204e5e-10ef-4758-8fc6-cb710048c687.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Carbidopa	CARBIDOPA TABLETS	Oceanside Pharmaceuticals	d5204e5e-10ef-4758-8fc6-cb710048c687	2020-07-02	Warnings, Adverse reactions	Exact identifier application applno (NDA): 017830 application number: NDA017830 ndc (product): 68682-200
Lodosyn	CARBIDOPA	Bausch Health US, LLC	ff8e105b-7415-42d4-bbb2-b36cfb8945a5	2020-07-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 017830 application number: NDA017830

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
MNX7R8C5VO	CARBIDOPA	38821-49-7	CARBIDOPA

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
260260	carbidopa 25 MG Oral Tablet	PSN	d5204e5e-10ef-4758-8fc6-cb710048c687	8
260260	carbidopa 25 MG Oral Tablet	SCD	d5204e5e-10ef-4758-8fc6-cb710048c687	8

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68682-200-25	68682020025	100 TABLET in 1 BOTTLE (68682-200-25)	100 tablet	2014-04-04	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Carbidopa Tablets	Oceanside Pharmaceuticals \| Bausch Health Companies, Inc.	2020-07-02	HUMAN PRESCRIPTION DRUG LABEL	8